Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LATANOPROST vs LECANEMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LATANOPROST vs LECANEMAB: Safety Overview

Metric LATANOPROST LECANEMAB
Total FAERS Reports 15,362 171
Deaths Reported 309 27
Death Rate 2.0% 15.8%
Hospitalizations 873 101
Average Patient Age 71.9 yrs 74.2 yrs
% Female Patients 65.9% 64.1%
FDA Approval Date Apr 14, 2025 N/A
Manufacturer Thea Pharma Inc. Eisai Inc.
Route OPHTHALMIC INTRAVENOUS
Marketing Status Prescription N/A